Walgreens provides clinically validated home infusion PROMs, an indicator of therapy success
DEERFIELD, Ill. — Walgreens immunoglobulin home infusion patients reported health outcomes consistent with reported outcomes gathered by the patients’ physicians in the clinical setting, according to new Walgreens PartnerPoint Clinical Management platform data presented Friday at the American Academy of Neurology 2014 Annual Meeting in Philadelphia. This outcome analysis is the first to validate patient-reported outcomes measures gathered by any home infusion provider administering IG therapy, a treatment projected to be ordered 10% more often each year that is increasingly provided in the home setting.
Walgreens utilized its PartnerPoint Clinical Management platform — a single solution, interactive clinical system — to capture reported outcomes for patients receiving home IG for either chronic inflammatory demyelinating polyneuropathy or myositis. The outcomes analysis found the difference between doctor and Walgreens Infusion Services pharmacist-collected PROMs was less than 10% for all IG treatment response measures combined. The results suggest PROMs gathered by Walgreens Infusion Services providers are clinically reliable for physicians overseeing patient care.
“Until now, physicians haven’t had access to clinically validated home infusion PROMs, an increasingly important indicator of overall patient wellness and therapy success," said Lisa Betts, Walgreens program director of immunoglobulin. "At Walgreens, we interact with IG patients regularly and want to provide valid and useful information about patient experiences to our physician partners.” she said. “Regular reporting of PROMs gathered by home infusion clinicians can supplement clinical outcomes and may help the treating physician assess patient response to therapy and make adjustments to help improve health outcomes.”
Walgreens PartnerPoint Clinical Management data is currently available to physicians and other patient care partners via Walgreens IG clinicians, the company noted. Direct access to the interactive clinical system is expected to be available to patient care partners by this summer, providing access to clinical reports, payer reports and PROMs.
“PartnerPoint is a new paradigm for IG management,” said Tahseen Mozaffar, director of the University of California, Irvine School of Medicine Neuromuscular Program and a member of Walgreens IG Medical Advisory Board. “We needed an evidence-based system to assess IG patient care delivered at home. PartnerPoint promises to deliver that system.”
Kroger to deploy a fleet of heavy-duty trucks that run on liquid natural gas
CINCINNATI — Kroger on Tuesday announced that it will be the first in Oregon to deploy a fleet of heavy-duty trucks that run on liquid natural gas. The 40 trucks will replace 40 diesel trucks currently in use, and are expected to start making store deliveries in the Portland metropolitan area by the end of 2014.
The use of natural gas fuel not only reduces operating costs for vehicles, but also reduces greenhouse gas emissions up to 23% in medium- to heavy-duty vehicles.
"This is the first step in Kroger’s effort to transition our fleet to alternative fuels," stated Kevin Dougherty, Kroger’s group VP and chief supply chain officer. "Converting to LNG trucks will allow us to reinvest savings into lower prices for our customers while also benefitting the environment."
The trucks will make deliveries to about 50 Fred Meyer and QFC stores as far south as Corvallis, Ore., and as far north as Longview, Wash., averaging approximately 175 mi. per day, six days a week, 52 weeks a year. They are expected to reduce greenhouse gas emissions by approximately 755 metric tons per year, which equates to removing approximately 159 passenger cars from the road annually. The fleet will be fueled at a new, private LNG fueling station at Kroger’s Clackamas Distribution Center, which will be designed and engineered by Clean Energy Fuels Corp.
"These trucks are nearly identical to our diesel fleet, which allows us to have minimal impact on operations and still achieve the same caliber and standard of performance," stated Matt Hoffman, Kroger regional logistics director, based in Portland. "They are truly the prototype truck of the future — the safest, cleanest and quietest way for our hard-working drivers to deliver product to the stores."
Coca-Cola to eliminate controversial ingredient
ATLANTA — Coca-Cola on Monday announced that it's eliminating brominated vegetable oil in its products after consumers reached out to express their objections to the ingredient, according to a report from the New York Times. Brominated vegetable oil contains bromine, an element that's also found in flame retardents. The company didn't list the products that contain bromine.
“Brominated vegetable oil is used in some of our beverages to improve the stability of our products, preventing certain ingredients from separating,” the company is quoted as saying. “All our beverages, including those with B.V.O., are safe and have always been — and comply with all regulations in the countries where they are sold.”
A Change.org petition, which garnered nearly 60,000 signatures, was started that called on Coca-Cola to eliminate brominated vegetable oil from Powerade. The company said it would replace the oil with sucrose acetate isobutyrate and glycerol ester of rosin. It plans to phase out the ingredient from all of its beverages by the end of the year.